Tumour microenvironment: Means of resistance

Nature Reviews Cancer

Volumn 13, Issue 9, 2013, Pages 607-

  Seton Rogers, Sarah ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; MONOCLONAL ANTIBODY; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

BONE MARROW CELL; CANCER RESISTANCE; COLORECTAL CANCER; COLORECTAL CARCINOMA; DRUG TARGETING; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; STROMA; TH17 CELL; TUMOR MICROENVIRONMENT; TUMOR VOLUME;

ANGIOGENESIS INHIBITORS; ANIMALS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; INTERLEUKIN-17; MALE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TH17 CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883157426     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3588     Document Type: Note

References (1)

1. Chung, A. S. et al. An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nature Med. http://dx.doi.org/10. 1038/nm.3291 (2013)